Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2394 | 2259 | 38.2 | 70% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
209 | 3 | GHRELIN//ADRENOMEDULLIN//NEUROPEPTIDE Y | 51926 |
3039 | 2 | NEUROTENSIN//NEUROTENSIN RECEPTOR//SR 48692 | 2465 |
2394 | 1 | NEUROTENSIN//NEUROTENSIN RECEPTOR//SR 48692 | 2259 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | NEUROTENSIN | authKW | 4876422 | 27% | 60% | 601 |
2 | NEUROTENSIN RECEPTOR | authKW | 1195706 | 5% | 83% | 106 |
3 | SR 48692 | authKW | 1027171 | 3% | 100% | 76 |
4 | NEUROMEDIN N | authKW | 407336 | 2% | 84% | 36 |
5 | XENIN | authKW | 297900 | 1% | 96% | 23 |
6 | SR142948A | authKW | 256793 | 1% | 100% | 19 |
7 | NT69L | authKW | 229762 | 1% | 100% | 17 |
8 | PD149163 | authKW | 148669 | 0% | 100% | 11 |
9 | NEUROTENSIN RECEPTOR 1 | authKW | 142752 | 1% | 81% | 13 |
10 | NEUROTENSIN ANTAGONISTS | authKW | 136279 | 0% | 92% | 11 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Neurosciences | 10817 | 41% | 0% | 921 |
2 | Endocrinology & Metabolism | 4715 | 18% | 0% | 416 |
3 | Pharmacology & Pharmacy | 4299 | 27% | 0% | 608 |
4 | Physiology | 1368 | 9% | 0% | 211 |
5 | Biochemistry & Molecular Biology | 677 | 18% | 0% | 415 |
6 | Gastroenterology & Hepatology | 250 | 4% | 0% | 90 |
7 | Chemistry, Medicinal | 138 | 3% | 0% | 70 |
8 | Behavioral Sciences | 135 | 2% | 0% | 50 |
9 | Medicine, Research & Experimental | 133 | 4% | 0% | 92 |
10 | Psychiatry | 85 | 3% | 0% | 76 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INSERM U339 | 88454 | 1% | 55% | 12 |
2 | MAYO PROT CORE IL | 67577 | 0% | 100% | 5 |
3 | MAYO CHEM CORE IL | 56313 | 0% | 83% | 5 |
4 | U339 | 56293 | 1% | 28% | 15 |
5 | NEUROPSYCHOPHARMACOL | 33249 | 2% | 6% | 44 |
6 | MAYO FDN MED EDUC | 31527 | 0% | 33% | 7 |
7 | ANO TOUMBA POLYCLIN | 27031 | 0% | 100% | 2 |
8 | FYMU | 27031 | 0% | 100% | 2 |
9 | GDR ANTIBODIES THER EUT TARGETING 3260 | 27031 | 0% | 100% | 2 |
10 | HOP UNIV COCHIN HOTEL DIEU BROCA | 27031 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PEPTIDES | 29297 | 6% | 2% | 138 |
2 | REGULATORY PEPTIDES | 18696 | 4% | 2% | 81 |
3 | NEUROPEPTIDES | 10244 | 2% | 2% | 44 |
4 | BRAIN RESEARCH | 6510 | 7% | 0% | 153 |
5 | EUROPEAN JOURNAL OF PHARMACOLOGY | 4213 | 4% | 0% | 95 |
6 | ANNALS OF THE NEW YORK ACADEMY OF SCIENCES | 4200 | 5% | 0% | 113 |
7 | NEUROSCIENCE | 3091 | 3% | 0% | 72 |
8 | ACTA PHYSIOLOGICA SCANDINAVICA | 2977 | 2% | 1% | 35 |
9 | MOLECULAR BRAIN RESEARCH | 1685 | 1% | 1% | 24 |
10 | SYNAPSE | 1613 | 1% | 1% | 20 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NEUROTENSIN | 4876422 | 27% | 60% | 601 | Search NEUROTENSIN | Search NEUROTENSIN |
2 | NEUROTENSIN RECEPTOR | 1195706 | 5% | 83% | 106 | Search NEUROTENSIN+RECEPTOR | Search NEUROTENSIN+RECEPTOR |
3 | SR 48692 | 1027171 | 3% | 100% | 76 | Search SR+48692 | Search SR+48692 |
4 | NEUROMEDIN N | 407336 | 2% | 84% | 36 | Search NEUROMEDIN+N | Search NEUROMEDIN+N |
5 | XENIN | 297900 | 1% | 96% | 23 | Search XENIN | Search XENIN |
6 | SR142948A | 256793 | 1% | 100% | 19 | Search SR142948A | Search SR142948A |
7 | NT69L | 229762 | 1% | 100% | 17 | Search NT69L | Search NT69L |
8 | PD149163 | 148669 | 0% | 100% | 11 | Search PD149163 | Search PD149163 |
9 | NEUROTENSIN RECEPTOR 1 | 142752 | 1% | 81% | 13 | Search NEUROTENSIN+RECEPTOR+1 | Search NEUROTENSIN+RECEPTOR+1 |
10 | NEUROTENSIN ANTAGONISTS | 136279 | 0% | 92% | 11 | Search NEUROTENSIN+ANTAGONISTS | Search NEUROTENSIN+ANTAGONISTS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ST-GELAIS, F , JOMPHE, C , TRUDEAU, LE , (2006) THE ROLE OF NEUROTENSIN IN CENTRAL NERVOUS SYSTEM PATHOPHYSIOLOGY: WHAT IS THE EVIDENCE?.JOURNAL OF PSYCHIATRY & NEUROSCIENCE. VOL. 31. ISSUE 4. P. 229-245 | 250 | 78% | 63 |
2 | CACEDA, R , KINKEAD, B , NEMEROFF, CB , (2006) NEUROTENSIN: ROLE IN PSYCHIATRIC AND NEUROLOGICAL DISEASES.PEPTIDES. VOL. 27. ISSUE 10. P. 2385-2404 | 228 | 80% | 60 |
3 | BINDER, EB , KINKEAD, B , OWENS, MJ , NEMEROFF, CB , (2001) NEUROTENSIN AND DOPAMINE INTERACTIONS.PHARMACOLOGICAL REVIEWS. VOL. 53. ISSUE 4. P. 453 -486 | 249 | 75% | 151 |
4 | GEISLER, S , BEROD, A , ZAHM, DS , ROSTENE, W , (2006) BRAIN NEUROTENSIN, PSYCHOSTIMULANTS, AND STRESS - EMPHASIS ON NEUROANATOMICAL SUBSTRATES.PEPTIDES. VOL. 27. ISSUE 10. P. 2364-2384 | 178 | 83% | 32 |
5 | FILIP, M , FERRARO, L , FASIOLO, LT , BEGGIATO, S , BORELLI, AC , POMIERNY-CHAMIOLO, L , FRANKOWSKA, M , ANTONELLI, T , TOMASINI, MC , FUXE, K , (2016) NEUROTENSIN: A ROLE IN SUBSTANCE USE DISORDER?.JOURNAL OF PSYCHOPHARMACOLOGY. VOL. 30. ISSUE 2. P. 112 -127 | 111 | 84% | 2 |
6 | ROSTENE, WH , ALEXANDER, MJ , (1997) NEUROTENSIN AND NEUROENDOCRINE REGULATION.FRONTIERS IN NEUROENDOCRINOLOGY. VOL. 18. ISSUE 2. P. 115 -173 | 216 | 72% | 97 |
7 | DOBNER, PR , (2005) MULTITASKING WITH NEUROTENSIN IN THE CENTRAL NERVOUS SYSTEM.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 62. ISSUE 17. P. 1946 -1963 | 163 | 73% | 36 |
8 | TANGANELLI, S , ANTONELLI, T , TOMASINI, MC , BEGGIATO, S , FUXE, K , FERRARO, L , (2012) RELEVANCE OF DOPAMINE D-2/NEUROTENSIN NTS1 AND NMDA/NEUROTENSIN NTS1 RECEPTOR INTERACTION IN PSYCHIATRIC AND NEURODEGENERATIVE DISORDERS.CURRENT MEDICINAL CHEMISTRY. VOL. 19. ISSUE 3. P. 304-316 | 117 | 77% | 12 |
9 | FERRARO, L , TOMASINI, MC , BEGGIATO, S , GUERRINI, R , SALVADORI, S , FUXE, K , CALZA, L , TANGANELLI, S , ANTONELLI, T , (2009) EMERGING EVIDENCE FOR NEUROTENSIN RECEPTOR 1 ANTAGONISTS AS NOVEL PHARMACEUTICS IN NEURODEGENERATIVE DISORDERS.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 9. ISSUE 12. P. 1429-1438 | 92 | 94% | 8 |
10 | BOULES, M , FREDRICKSON, P , RICHELSON, E , (2005) NEUROTENSIN AGONISTS AS AN ALTERNATIVE TO ANTIPSYCHOTICS.EXPERT OPINION ON INVESTIGATIONAL DRUGS. VOL. 14. ISSUE 4. P. 359-369 | 112 | 84% | 18 |
Classes with closest relation at Level 1 |